Competitor Analysis: HIV Small Molecule Therapeutics

La Merie Publishing
December 1, 2011
100 Pages - SKU: LAM3790119
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.


Additional Information

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

More Drug Discovery reports by La Merie Publishing

Engineered TCR and CAR Immunotherapeutics 2015 by La Merie Publishing
Engineered TCR and CAR Immunotherapeutics 2015 The engineered T cell receptor (TCR) for targeting of intracellur targets not druggable by conventional antibody technologies, ...
Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators by La Merie Publishing
The Competitive Intelligence report about IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as ...
Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease by La Merie Publishing
Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease The Competitive Intelligence report about Alpha Synuclein and LRRK2 ...
Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates by La Merie Publishing
Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 642  
    Global Site License  USD 1,926  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!